NCT00738023View on ClinicalTrials.gov

Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Type 2 DiabetesHypertension
Interventions
DRUG

Rosiglitazone

Diabetic subjects will be receive rosiglitazone for 6 weeks

DRUG

Normal saline 0.9%

Normal saline 0.9% intravenous infusion at 40ml/hr for 48 hours

DRUG

Intralipid 20%

Intralipid 20% at 40ml/hr intravenously for 48 hours

Trial Locations (1)

30303

Grady Memorial Hospital, Atlanta

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Emory University

OTHER